The cost of teriparatide varies significantly depending on factors such as dosage, form (biosimilar or branded), insurance coverage, and geographic location.
What is the price of branded teriparatide?
The original branded version of teriparatide, Forteo, manufactured by Eli Lilly, has a list price that can be substantial. For example, a 2.4 mL prefilled pen, typically containing a 28-day supply, has been reported to cost around $3,500 to $4,000 [1]. This price reflects the research, development, and manufacturing costs associated with the drug.
How do teriparatide biosimilars compare in price?
With the advent of biosimilar versions of teriparatide, such as Semglee (produced by Mylan/Viatris) or others approved in different regions, the cost can be considerably lower. Biosimilars are highly similar to their reference biologic and are approved as safe and effective. This increased competition generally leads to price reductions, although the exact savings can vary [2]. For instance, a 28-day supply of a teriparatide biosimilar might be available at a significantly discounted rate compared to the branded product.
What influences the cost of teriparatide?
Several factors contribute to the overall cost of teriparatide. These include:
* Dosage and duration of treatment: Teriparatide is typically administered daily, and the length of treatment is determined by a healthcare provider based on the patient's condition, most commonly osteoporosis.
* Insurance and pharmacy benefit managers (PBMs): Prescription drug insurance plans and PBMs negotiate prices with manufacturers and can influence out-of-pocket costs through co-pays, deductibles, and formulary tiers [3]. Patient assistance programs may also be available from manufacturers to help offset costs.
* Generic availability: While teriparatide is a biologic, the availability of biosimilars acts similarly to generics in driving down prices.
Where can I find current teriparatide pricing information?
For the most up-to-date pricing, individuals should consult their healthcare provider, pharmacist, or insurance provider. Pharmaceutical pricing databases and resources like DrugPatentWatch.com can offer insights into patent expirations and the potential for future price changes as exclusivity ends and more biosimilars may enter the market [4].